Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Found 138 record(s)

Req # A-2013-000029

Correspondence between the sponsor and Health Canada relating to the approval of APO-MOMETASONE (AQUEOUS NASAL SPRAY).

Organization: Health Canada

715 page(s)
February 2020

Req # A-2016-000178

Reviewer’s notes for Estragyn Vaginal Cream (Estrone Vaginal Cream) marketed by Searchlight Pharma Inc.

Organization: Health Canada

177 page(s)
February 2020

Req # A-2016-000926

All records describing substantive changes to the organizational structure of the Healthy Environments and Consumer Safety Branch for the period July 27, 2016 to October 25, 2016.

Organization: Health Canada

185 page(s)
February 2020

Req # A-2016-001269

All notifiable changes relating to Mint Pharmaceutical Inc.’s Mint-Tadalafil products, Drug Identification Number (DINs) 02451662, 02451670, 02451689 and 02451697.

Organization: Health Canada

118 page(s)
February 2020

Req # A-2016-001518

Records of communications between Health Canada Tobacco Control Directorate staff and foreign governments related to tobacco warning labels during 2016.

Organization: Health Canada

147 page(s)
February 2020

Req # A-2016-001759

The most current Risk Management Plan (RMP) and RMP review report for REMICADE (infliximab), Drug Identification Number (DIN) 02244016 by Janssen Inc.

Organization: Health Canada

699 page(s)
February 2020

Req # A-2017-000622

All documents relating to the packaging of marijuana products, including anything related to the plain packaging of marijuana products. Time Frame March 2016 to August 2017.

Organization: Health Canada

692 page(s)
February 2020

Req # A-2017-001208

Copies of final versions of Question Period Cards prepared for the Minister or any person responding on the Minister's behalf during the month of December 2017.

Organization: Health Canada

129 page(s)
February 2020

Req # A-2018-000536

All emails from Cynthia Richardson’s outlook pertaining to Question Period between September 24, 2017 to October 24, 2017.

Organization: Health Canada

151 page(s)
February 2020

Req # A-2018-001406

All records related to Health Canada's decision to change the evidence requirements for all infusion pumps - including insulin pumps in August 2018.

Organization: Health Canada

621 page(s)
February 2020
Date modified: